Aaron Akulis
Aaron Akulis
POD47. Dr Bethany Halford
POD47. Dr Bethany Halford
POD47. Dr Bethany Halford
Wednesday 1st June 2022
Dive into the potential of psychedelics and nanotechnology in mental health with Dr Bethany Halford on 'The Peace On Drugs' podcast.
50 minutes
Informative
Thought-provoking
Raw
Engaging
Educational
About this podcast
Author:
Aaron Akulis
Overview:
Categories:
Understanding Addiction & Recovery
Family Recovery from Addiction
Sobriety Toolkit
Creative Recovery Journeys
Body & Mind
Links:
Visit site
Episodes:
94 (View all)
Do you want to link to this podcast?
Get the buttons here!Psychedelics and Nanotechnology: A Conversation with Dr Bethany Halford
We're so scared of the mystical experiences. I don't think we would have used it for covid until we figured out how to demystify it.
Ever wondered how psychedelics could revolutionize mental health treatment? In this episode of 'The Peace On Drugs', Aaron Akulis sits down with Dr Bethany Halford, a seasoned science writer and senior correspondent at Chemical and Engineering News. Dr Halford shares her journey from synthetic organic chemistry to becoming a prominent voice in science communication. The chat dives deep into the promising world of nanotechnology, including the futuristic idea of using nanobots to combat viruses and craft new medicines.
But it doesn't stop there. The conversation shifts to the therapeutic potential of psychedelics. Dr Halford sheds light on how these substances can spark profound mystical experiences that foster forgiveness and self-understanding. They also tackle the cultural stigmas surrounding psychedelics and the pressing need to demystify them for broader acceptance in mental health care. Ketamine, often dubbed a game-changer in mental health, also gets its spotlight.
Dr Halford discusses its research and the quest for more accessible treatments that don't tether patients to prolonged doctor visits. This episode is a treasure trove of insights for anyone curious about the future of medicine and mental health. It's not just informative; it's a call to rethink and embrace groundbreaking treatments.